Feed - News and features

• Lifeline for Wolman disease kids as NICE backs Alexion drug
  Infants with a rare and fatal...
• Dupixent aces second COPD study, setting up FDA filing
  With a second positive phase 3 trial...
• Is GSK’s Blenrep heading for a renaissance?
  A year after GSK pulled its...
• Digital programme improves metabolic health in diabetes
  A comprehensive digital approach to...

PharmaTimes: News RSS

• MHRA launches online eligibility checker tool via the IRP
• New NHS software set to improve care for millions of patients
• Study suggests cognitive decline could be linked to hippocampus shrinkage
• NHS urges individuals to take up cervical screening invitations
• Alladapt’s allergy treatment receives FDA fast track designation

• Consumption of antimicrobials in animals reaches lowest level ever in Europe, , 20/11/2023
• Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 7-9 November 2023, CVMP, 10/11/2023
• Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 6-9 November 2023, CHMP, 10/11/2023
• Getting ready for EMA’s website relaunch on 5 December 2023, , 09/11/2023

• Delayed Cold-Stored Platelets -PLTS-1
• Urinary Retention Following taTME VS laTME Total Mesorectal Excision for Rectal Cancer
• ED90 of Bupivacaine After Lidocaine Test Dose With DPE and EPL
• Human Induced Pluripotent Stem Cells Derived Natural Killer Cell(XS005) Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)